BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Italfarmaco R&D Head Shares Strong Clinical Data at ASH

  Italfarmaco has its eyes set on bringing a new treatment that targets the underlying mechanism of the blood disorder Polycythemia Vera.

  December 21, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Genetown

  Primary Endpoint Met in Corvia Medical’s Reduce LAP-HF I Study

  Corvia Medical said its investigational transcatheter structural heart device to treat heart failure has demonstrated success in reducing exercise pulmonary capillary wedge pressure in trial patients.

  December 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Celgene Crashed After Follicular Lymphoma Regimen Failed Phase III

  Celgene announced the Phase III results late Thursday and share prices dropped about 4 percent to $102.69 as of 9:30 this morning.

  December 21, 2017

   · 

  2 min read

   · 

  Alex Keown